(Q43724540)

26 November 2017

title

Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice (English)

1 reference

26 November 2017

vaccinia virus

1 reference

D F Smee

1

1 reference

26 November 2017

K W Bailey

series ordinal

2

1 reference

26 November 2017

M H Wong

series ordinal

3

1 reference

26 November 2017

R W Sidwell

series ordinal

4

1 reference

26 November 2017

publication date

1 October 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

52

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

55-62

1 reference

Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Topical cidofovir for severe molluscum contagiosum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

1 reference

7 January 2021

Efficacy of cidofovir in the treatment of recalcitrant molluscum contagiosum in an AIDS patient

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Progressive vaccinia treated with ribavirin and vaccinia immune globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

THE BEHAVIOR OF POX VIRUSES IN THE RESPIRATORY TRACT : I. THE RESPONSE OF MICE TO THE NASAL INSTILLATION OF VACCINIA VIRUS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Parapoxviruses are strongly inhibited in vitro by cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Respiratory infection of mice with vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900159-0

7 January 2021

10.1016/S0166-3542(01)00159-0

Identifiers

DOI

1 reference

26 November 2017

1 reference